<DOC>
	<DOCNO>NCT00942604</DOCNO>
	<brief_summary>The purpose study determine whether topical application PEP005 effective treatment actinic keratoses .</brief_summary>
	<brief_title>A Multicenter Study Evaluate Efficacy Safety PEP005 ( Ingenol Mebutate ) Gel When Used Treat Actinic Keratoses ( AKs ) Non Head Locations</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Must male female least 18 year age . Female patient must : Nonchildbearing potential ; Childbearing potential , provide negative serum urine pregnancy test use effective contraception . 4 8 AK lesion nonhead location . Cosmetic therapeutic procedure within 2 week within 2 cm select treatment area . Treatment immunomodulators , interferon/ interferon inducer systemic medication suppress immune system within 4 week . Treatment 5FU , imiquimod , diclofenac , photodynamic therapy within 8 week 2 cm treatment area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Peplin</keyword>
	<keyword>Actinic keratosis</keyword>
	<keyword>PEP005</keyword>
</DOC>